Century Casinos (CNTY) Reports Q2 Loss, Lags Revenue Estimates
Century Casinos (CNTY) came out with a quarterly loss of $1.36 per share versus the Zacks Consensus Estimate of a loss of $0.40. This compares to loss of $0.06 per share a year ago.
3 Budget-Friendly Stocks With Millionaire-Making Potential
Investors with a high tolerance for risk looking for huge returns often find budget-friendly stocks to be a great option. While low-valued stocks often have a bad reputation due to their accompanying risk, it's important to find some gems with enough research.
Century Therapeutics: Cell Therapy Biotech With Expanded Potential Of CNTY-101
Positive poster presentation results were released at ASCO 2024 from the phase 1 ELiPSE-1 study, which used CNTY-101 for the treatment of patients with relapsed/refractory CD19-positive non-Hodgkin lymphoma patients. The global non-Hodgkin Lymphoma market is expected to surge to $11 billion by 2029. Initiation of phase 1 CALiPSO-1 study, using CNTY-101 for patients with systemic lupus erythematosus, is expected in the 1st half of 2024; Data from this study is to be released 2nd half of 2024.
